This site is intended for healthcare professionals

Positive results from randomized controlled trial of CP1 01, an oral microbiome drug, for the prevention of recurrent C. difficile infection.-Finch Therapeutics Group

Read time: 1 mins
Last updated:16th Mar 2021
Published:21st Jun 2020
Condition: Infectious Diseases/Clostridium
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest